National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M01AH05	COXIFLAM	G	Etoricoxib - 60mg	60mg	Tablet, film coated	1,109,630 L.L
N05AA01	CHLORPROMAZINE	G	Chlorpromazine HCl - 50mg	50mg	Tablet	332,761 L.L
B05D	CAPD/DPCA 2Solution for peritoneal dialysis stay safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Glucose monohydrate - 16.5g/l		Injectable solution	707,716 L.L
B05D	CAPD/DPCA 3Solution for peritoneal dialysis	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.2573g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 42.50g/l, Glucose monohydrate - 46.75g/l		Injectable solution	740,031 L.L
B05D	CAPD/DPCA 17Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 15g/l, Fructose , - up to 0.75g/l		Injectable solution	715,794 L.L
B05D	CAPD/DPCA 19Solution for peritoneal dialysis sleep safe	G	Sodium chloride - 5.786g/l, Sodium-(S)-lactate - 3.925g/l, Calcium chloride 2H2O - 0.1838g/l, Magnesium chloride, 6H2O - 0.1017g/l, Anhydrous glucose - 22.73g/l, Fructose , - up to 1.1g/l		Injectable solution	715,794 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	712,237 L.L
J01DC10	CEFPROZ 250	G	Cefprozil - 250mg/5ml	250mg/5ml	Powder for suspension	1,343,843 L.L
J01DD01	CEFOTAX	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	217,702 L.L
M01AH05	CLINTON	G	Etoricoxib - 90mg	90mg	Tablet, film coated	454,219 L.L
J01DD01	CEFOTAXIME PANPHARMA	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution	6,127,922 L.L
M01AH05	CLINTON	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,280,682 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
J01DD01	CLAFOCARE	G	Cefotaxime (sodium) - 1g	1g	Injectable powder for solution	8,031,731 L.L
M01AH05	CONSORT	G	Etoricoxib - 90mg	90mg	Tablet, film coated	338,648 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
M01AH05	COXIFLAM	G	Etoricoxib - 90mg	90mg	Tablet, film coated	1,293,928 L.L
J01DD02	CEFTAZIDIME PANPHARMA	G	Ceftazidime (pentahydrate) - 1g	1g	Injectable powder for solution	3,300,477 L.L
D10BA01	CONTRACNE ISOTRETINOINE	G	Isotretinoin - 20mg	20mg	Capsule, soft	1,521,230 L.L
D10BA01	CURACNE	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,603,204 L.L
R03BA01	CORTIS	G	Beclometasone dipropionate - 250mcg/actuation	250mcg/actuation	Inhalation solution	674,609 L.L
D10BA01	CURACNE	G	Isotretinoin - 20mg	20mg	Capsule, soft gelatin	1,603,204 L.L
B05XA01	CHLORURE DE POTASSIUM PROAMP	G	Potassium chloride - 0.0746g/ml	0.0746g/ml	Injectable concentrated solution	1,252,461 L.L
D10BA01	CURACNE	G	Isotretinoin - 5mg	5mg	Capsule, soft gelatin	856,028 L.L
B05XA01	CHLORURE DE POTASSIUM RENAUDIN	G	Potassium chloride - 7.46g/100ml	7.46%	Injectable solution	385,683 L.L
D10BA01	CURACNE	G	Isotretinoin - 5mg	5mg	Capsule, soft gelatin	856,028 L.L
M01AH05	CLINTON	G	Etoricoxib - 120mg	120mg	Tablet, film coated	362,837 L.L
M01AH05	CONSORT	G	Etoricoxib - 120mg	120mg	Tablet, film coated	309,084 L.L
D10BA01	CONTRACNE ISOTRETINOINE	G	Isotretinoin - 40mg	40mg	Capsule, soft	3,043,803 L.L
M01AH05	COXIFLAM	G	Etoricoxib - 120mg	120mg	Tablet, film coated	398,033 L.L

National Cancer Registry (NCR)